QSAM BIOSCI. DL-,0001 Aktie - Unternehmensdaten & Kurse - US74738N2027 | MoneyPeak

QSAM BIOSCI. DL-,0001

Share · US74738N2027 · A3DJED (XNCM)

No Price

n/a

Company Profile for QSAM BIOSCI. DL-,0001 Share

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.

Get up to date insights from finAgent about QSAM BIOSCI. DL-,0001

Company Data

Name QSAM BIOSCI. DL-,0001

Company QSAM Biosciences, Inc.

Website https://qsambio.com

Primary Exchange

Frankfurt

WKN A3DJED

ISIN US74738N2027

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Douglas R. Baum

Country United States of America

Currency EUR

Employees 0,0 T

Address Plaza 1, 78759 Austin

IPO Date 2012-08-13

Ticker Symbols

Name	Symbol
Over The Counter	QSAM

More Shares

Investors who hold QSAM BIOSCI. DL-,0001 also have the following shares in their portfolio:

DZ BANK CLN E.9318 Bond

INVESTEC BANK PLC KO NTS CAR 11/02/25 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025